News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
07
2025
-
07
Mission calls for action, and we move forward! Linuo Pharmaceuticals held its 2025 semi-annual marketing conference, uniting consensus and embarking on a new journey!
Classification：
行业新闻
Corporate News
To comprehensively review the first half of the year's marketing work, accurately analyze the market situation, empower the second half of the year's work, and help achieve the annual task targets, Linov Pharmaceutical grandly held its 2025 semi-annual marketing conference on July 5th and 6th. Company leaders, all members of the marketing center, and heads of relevant departments gathered together to conduct an in-depth analysis of the completion of tasks in the first half of the year, laying a solid foundation for achieving the annual marketing goals.
In order to better adapt to market changes and improve the professional capabilities of the marketing team, the conference specially arranged a wealth of training and exchange sessions, covering new product knowledge, financial management systems, price maintenance systems, and human resource systems. Through interactive exchanges and case studies, marketing personnel broadened their horizons, updated their concepts, and mastered more practical marketing skills and methods, laying a solid foundation for the second half of the year's work.
The conference opened with a group singing of the Linov song and a group recitation of the Linov motto. Marketing heads from all over the country took the stage one by one, combining the market characteristics and actual sales situations of their respective regions to give detailed work reports. They conducted in-depth analyses of the market competitive landscape, shared successful experiences, and proposed practical improvement measures for existing problems. The heads of each region also clearly explained their work plans and goals for the second half of the year, formulating detailed marketing promotion plans, demonstrating firm confidence and determination.
In the strategic deployment session, Chairman Li Hongfu put forward clear requirements and strategic plans for the second half of the year's marketing work. He emphasized the need to closely follow the company's development strategy, focus on core products and key markets, increase market promotion efforts, and enhance brand awareness and reputation; to continuously optimize the product structure, accelerate the market introduction of new products, and meet the needs of different customers; to strengthen team building, improve the team's execution and collaboration capabilities, and build a highly efficient, professional, and combat-ready marketing team. In addition, he encouraged marketing personnel to be brave in innovation, actively explore new marketing models and channels, continuously improve market competitiveness, and ensure the successful completion of the year's marketing tasks.
The conference also held a grand commendation ceremony for individuals who performed outstandingly in the marketing work of the first half of the year. By setting examples, it encouraged all marketing personnel to devote themselves to the work of the second half of the year with even greater enthusiasm and high spirits. Award-winning representatives stated in their speeches that they would cherish the honor, continue to strive for excellence, and make greater contributions to the company's development.
The successful convening of this semi-annual marketing conference has pointed the way and united the forces for Linov Pharmaceutical's marketing work in the second half of the year. All participants were deeply encouraged and their confidence greatly increased. Everyone expressed that they would take this conference as a new starting point, keep their mission in mind, work diligently and practically, with even firmer belief, a more pragmatic style, and more innovative measures, to make every effort to achieve the annual marketing goals and contribute to the company's high-quality development.
Related news
2026-05-18
On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China